About Perosphere Technologies
Perosphere Technologies is a Healthcare company based in Danbury (United States) founded in 2017. Point-of-care coagulation diagnostics and drug delivery systems are developed. Its chief executive, as recorded, is Sasha Bakhru. Perosphere Technologies offers products and services including Perosphere ClotChek, WBCT Assay, and Liquid Quality Controls. Its focus areas include Life Sciences, Hematology, In Vitro Diagnostics Tests and Coagulopathies. Its competitors include Hemosonics, Atantares and Stasys; 3 of its 3 listed competitors have raised funding.
Company details
Perosphere Technologies is a medical technologies company focused on the development of a point-of-care (PoC) coagulometer designed for broad-spectrum monitoring of coagulation status, including the activity of anticoagulants and their respective antidotes. The companys primary product is a point-of-care (PoC) coagulometer. The PoC coagulometer is a hand-held instrument that performs individual coagulation tests on fresh or citrated whole blood. The system is designed for broad-spectrum monitoring of the activity of anticoagulants and their corresponding antidotes, across drug classes, in a hospital setting at a patients bedside. A single test requires only roughly 10 microliters of fresh or citrated whole blood from a venous draw or finger stick. The system employs single-use, proprietary test strips containing no anticoagulant-specific chemical or biological reagents.
- Headquarters Danbury, United States
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website perospheretech.com
- Legal Name Perosphere Technologies
- Latest Funding Round$1.97M (USD), Grant
Sep 2023
- Investors
Products & Services of Perosphere Technologies
Perosphere Technologies offers a comprehensive portfolio of products and services, including Perosphere ClotChek, WBCT Assay, and Liquid Quality Controls.
Point-of-care device for rapid global coagulation status assessment.
Single-use test for coagulation monitoring in medical environments.
Controls for verifying normal and anticoagulated sample accuracy.
Funding Insights of Perosphere Technologies
- Total Rounds 1
- Last Round Grant — $1.97M
- First Round $1.97M
(Sep 2023)
- Investors Count 1
All 1 funding rounds of Perosphere Technologies with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep 2023 | $1.97M | Grant | – | – |
1 investors in total: 1 institutional.
Investors in Perosphere Technologies
Perosphere Technologies has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include HHS.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Public health and human services are overseen by HHS. | 1953 | hhs.gov |
Investor details for Perosphere Technologies
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Perosphere Technologies
8 people are tracked at Perosphere Technologies (5 in leadership, 3 in team).
| Name | Role | Group |
|---|---|---|
Sasha Bakhru | CEO & President | Leadership |
David Walker | Vice President Of EU Sales | Leadership |
Lirong Chen | Senior Director Of Research | Leadership |
Daryl Mootoo | Executive Vice President & Chief Operating Officer | Leadership |
Steven Ward | Executive Vice President & Chief Financial Officer | Leadership |
Alfredo C. | Information Technology Manager | Team |
Russ Dostilio | Controller | Team |
Kangwoo Choo | Software Engineer | Team |
Complete people profiles for Perosphere Technologies
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Perosphere Technologies
2 dated milestones of Perosphere Technologies across 6 years, from founding to its latest funding, stage changes and deals.
- Founded Perosphere Technologies is founded.
- Funding First funding round of $2.0M.
Competitors of Perosphere Technologies
Perosphere Technologies has 3 listed competitors in our database, 3 of them funded. They include Hemosonics, Atantares and Stasys.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| hemosonics.com | 2004 | Charlottesville, United States | $24.92M | IVD for hemostasis characterization | ||
| atantares.com | 2020 | Cambridge, United States | $13.99M | Developer of precision medicines & smart diagnostic devices by fusing biochip and AI technologies | ||
| stasysmedical.com | 2013 | Seattle, United States | $2.85M | Provider of POC device for analyzing blood clotting disorders and platelet dysfunction |
Detailed competitors of Perosphere Technologies
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Hematology
3 companies that operate in the same segment as Perosphere Technologies (Hematology) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Catheter-based thrombectomy devices for vascular emboli removal are developed. | 2011 | Irvine, California, United States | USD 51.89 M | USD 493.63 M | 696 | |
Small molecules are developed to treat hematologic and musculoskeletal disorders. | 2016 | Lexington, Kentucky, United States | USD 90 M | USD 244.06 M | 169 | |
Developer of Allogeneic cell therapy for cancer, autoimmune diseases and genetic blood disorders | 2016 | Menlo Park, California, United States | USD 300 M | 384 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Perosphere Technologies
Complete news archive for Perosphere Technologies
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Perosphere Technologies
Perosphere Technologies was founded in 2017 and raised its 1st funding round 6 years after it was founded.
Perosphere Technologies is headquartered in Danbury, United States. It is registered at Danbury, Connecticut, United States.
Sasha Bakhru is the CEO of Perosphere Technologies, as recorded in our data.
Perosphere Technologies is a medical technologies company focused on the development of a point-of-care (PoC) coagulometer designed for broad-spectrum monitoring of coagulation status, including the activity of anticoagulants and their respective antidotes. The companys primary product is a point-of-care (PoC) coagulometer. The PoC coagulometer is a hand-held instrument that performs individual coagulation tests on fresh or citrated whole blood. The system is designed for broad-spectrum monitoring of the activity of anticoagulants and their corresponding antidotes, across drug classes, in a hospital setting at a patients bedside. A single test requires only roughly 10 microliters of fresh or citrated whole blood from a venous draw or finger stick. The system employs single-use, proprietary test strips containing no anticoagulant-specific chemical or biological reagents.
Perosphere Technologies's top competitors include Hemosonics, Atantares and Stasys.
Perosphere Technologies offers Perosphere ClotChek, WBCT Assay, and Liquid Quality Controls.
Perosphere Technologies has 1 investor. Key investors include HHS.
Perosphere Technologies operates through Perosphere Technologies.